Skip to main content
CDC Website

HIV/AIDS

Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed)

The purpose of this notice of funding opportunity (NOFO) is to support the evaluation of early-stage diagnostics and novel diagnostic strategies for Tuberculosis (TB) in the context of existing clinical algorithms in TB endemic countries.

Limited Interaction Targeted Epidemiology: Epidemiology of Transmission and Treatment of HIV Among People Who Are at Increased Risk for HIV Infection in Latin America (LITE-LA) (UG3/UH3 Clinical Trial Optional)

The purpose of this notice of funding opportunity (NOFO) is to support investigators who will form large, electronically-generated cohorts in Latin America of HIV-negative men who have sex with men (MSM), transgender women (TGW), people who inject drugs (PWID), and/or female sex-workers and follow them to study the epidemiology of HIV incidence. Continued follow-up of those persons who acquire HIV will be required to study the epidemiology of viral suppression.

Capacity Building Assistance (CBA) for HIV Prevention Programs to End the HIV Epidemic in the United States

CDC announces the competitive availability of fiscal year 2024 funds to implement a capacity building assistance (CBA) program to strengthen the capacity and improve the performance of the nation’s HIV workforce. This notice of funding opportunity (NOFO) supports a network of funded providers, established and referenced as the CBA Provider Network (CPN), to implement the following six inter-related program components:

Component A: Technical Assistance to Enhance Integrated HIV Activities for Health Department Jurisdictions